Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Genome Announc ; 1(4)2013 Aug 22.
Article in English | MEDLINE | ID: mdl-23969054

ABSTRACT

Attenuated Salmonella enterica serovar Typhi strain Ty21a is an important vaccine for controlling typhoid fever and serves as an oral vector for delivering heterologous antigens. The key attenuating features of this randomly mutated strain remain in question. Genome sequencing has revealed 679 single nucleotide polymorphisms (SNPs), and will help define alterations contributing to Ty21a safety and immunogenicity.

2.
Aging (Albany NY) ; 4(2): 119-32, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22354768

ABSTRACT

The premature aging disorder, Hutchinson-Gilford progeria syndrome (HGPS), is caused by mutant lamin A, which affects the nuclear scaffolding. The phenotypic hallmark of HGPS is nuclear blebbing. Interestingly, similar nuclear blebbing has also been observed in aged cells from healthy individuals. Recent work has shown that treatment with rapamycin, an inhibitor of the mTOR pathway, reduced nuclear blebbing in HGPS fibroblasts. However, the extent of blebbing varies considerably within each cell population, which makes manual blind counting challenging and subjective. Here, we show a novel, automated and high throughput nuclear shape analysis that quantitatively measures curvature, area, perimeter, eccentricity and additional metrics of nuclear morphology for large populations of cells. We examined HGPS fibroblast cells treated with rapamycin and RAD001 (an analog to rapamycin). Our analysis shows that treatment with RAD001 and rapamycin reduces nuclear blebbing, consistent with blind counting controls. In addition, we find that rapamycin treatment reduces the area of the nucleus, but leaves the eccentricity unchanged. Our nuclear shape analysis provides an unbiased, multidimensional "fingerprint" for a population of cells, which can be used to quantify treatment efficacy and analyze cellular aging.


Subject(s)
Cell Nucleus Shape , Cellular Senescence , Progeria/pathology , Cell Nucleus Shape/drug effects , Cells, Cultured , Cellular Senescence/drug effects , Everolimus , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Image Processing, Computer-Assisted , Lamin Type A , Nuclear Proteins/metabolism , Progeria/drug therapy , Progeria/metabolism , Protein Precursors/metabolism , Sirolimus/analogs & derivatives , Sirolimus/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...